Cytokinetics Stock Future Price Prediction


USD 51.65  1.09  2.07%   

Cytokinetics stock price prediction is an act of determining the future value of Cytokinetics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cytokinetics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cytokinetics and does not consider all of the tangible or intangible factors available from Cytokinetics' fundamental data. We analyze noise-free headlines and recent hype associated with Cytokinetics, which may create opportunities for some arbitrage if properly timed.
Continue to Cytokinetics Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cytokinetics based on different types of headlines from major news networks to social media. The Cytokinetics stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cytokinetics over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytokinetics using Cytokinetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytokinetics using crowd psychology based on the activity and movement of Cytokinetics' stock price.
Cytokinetics Revenue to Assets are decreasing as compared to previous years. The last year's value of Revenue to Assets was reported at 0.08. The current Total Assets Per Share is estimated to increase to 10.71, while Cash and Equivalents Turnover is projected to decrease to 0.67.

Cytokinetics Short Interest

A significant increase or decrease in Cytokinetics' short interest from the previous month could be a good indicator of investor sentiment towards Cytokinetics. Short interest can provide insight into the potential direction of Cytokinetics stock and how bullish or bearish investors feel about the market overall. An investor who is long Cytokinetics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Cytokinetics and may potentially protect profits, hedge Cytokinetics with its derivative instruments, or be ready for some potential downside.
200 Day MA
Short Percent
Short Ratio
Shares Short Prior Month
11.8 M
50 Day MA
Shares Short
11.7 M

Cytokinetics Hype to Price Pattern

Investor biases related to Cytokinetics' public news can be used to forecast risks associated with investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cytokinetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cytokinetics.

Cytokinetics Implied Volatility

Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Cytokinetics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cytokinetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cytokinetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cytokinetics after-hype prediction price

  $ 54.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Cytokinetics contract

Based on the Rule 16, the options market is currently suggesting that Cytokinetics will have an average daily up or down price movement of about 6.3% per day over the life of the 2022-08-19 option contract. With Cytokinetics trading at $51.65, that is roughly $3.25. If you think that the market is fully incorporating Cytokinetics' daily price movement you should consider acquiring Cytokinetics options at the current volatility level of 100.81%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cytokinetics in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
11 Analysts
LowTarget PriceHigh
Estimates (8)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cytokinetics. Your research has to be compared to or analyzed against Cytokinetics' peers to derive any actionable benefits. When done correctly, Cytokinetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cytokinetics.

Cytokinetics After-Hype Price Prediction Density Analysis

As far as predicting the price of Cytokinetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytokinetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Cytokinetics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cytokinetics Estimiated After-Hype Price Volatility

In the context of predicting Cytokinetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytokinetics' historical news coverage. Cytokinetics' after-hype downside and upside margins for the prediction period are 49.13 and 58.87, respectively. We have considered Cytokinetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 51.65
After-hype Price
Cytokinetics is very steady asset. Analysis and calculation of next after-hype price of Cytokinetics is based on 3 months time horizon.

Cytokinetics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Cytokinetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytokinetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytokinetics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.49  4.87  0.46   0.15  9 Events / Month0 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Cytokinetics Hype Timeline

Cytokinetics is currently traded for 51.65. The entity has historical hype elasticity of 0.46 and average elasticity to hype of competition of 0.15. Cytokinetics is anticipated to increase in value after the next headline with price projected to jump to 54.0 or above. The average volatility of media hype impact on the company stock price is over 100%. The price growth on the next news is forecasted to be 0.86% whereas the daily expected return is currently at 0.49%. The volatility of related hype on Cytokinetics is about 1623.33% with expected price after next announcement by competition of 51.8. The company reported the previous year's revenue of 70.43 M. Net Loss for the year was (215.31 M) with loss before overhead, payroll, taxes, and interest of (89.51 M). Given the investment horizon of 90 days the next anticipatedpress releasewill be in about 9 days.
Continue to Cytokinetics Basic Forecasting Models to cross-verify your projections.

Cytokinetics Related Hype Analysis

Having access to credible news sources related to Cytokinetics' direct competition is more important than ever and may enhance your ability to predict Cytokinetics' future price movements. Getting to know how Cytokinetics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytokinetics may potentially react to the hype associated with one of its peers.
At Risk
ALVRAllovir 0.30 3 per month 5.79  0.14  13.96 (8.23)  30.02 

Cytokinetics Additional Predictive Modules

Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cytokinetics Predictive Indicators

The successful prediction of Cytokinetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cytokinetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cytokinetics based on analysis of Cytokinetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cytokinetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cytokinetics's related companies.
 2021 2022 (projected)
Long Term Debt to Equity0.590.56
Interest Coverage7.537.48

Story Coverage note for Cytokinetics

The number of cover stories for Cytokinetics depends on current market conditions and Cytokinetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytokinetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytokinetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cytokinetics Short Properties

Cytokinetics' future price predictability will typically decrease when Cytokinetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytokinetics often depends not only on the future outlook of the potential Cytokinetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytokinetics' indicators that are reflective of the short sentiment are summarized in the table below.
Average Daily Volume Last 10 Day1.57M
Average Daily Volume In Three Month1.36M
Continue to Cytokinetics Basic Forecasting Models to cross-verify your projections. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.6 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.